Ruth : Actualité Ruth en direct - P1 | Bourse Reflex
Accueil > Tags > Ruth

  • Toutes les actualités en rapport avec « Ruth »

20/02 18:00 Ruth - 2017 financial calendar - Quantum Genomics has joined the Pass French Tech program

29/11 18:15 Ruth - Initiation of coverage by Edison Investment Research

16/11 17:00 Ruth - Publication of the second issue of Quantum Genomics' shareholder newsletter - November, 2016

13/10 18:00 Ruth - Quantum Genomics announces 2016 first-half financial results and first nine months business update

29/09 17:45 Ruth - Quantum Genomics reports positive top-line results from Phase IIa trial of QGC001 in hypertension

22/09 18:00 Ruth - Quantum Genomics Announces Conference Call to Review Top-line Results from Phase IIa Study of QGC001 in Hypertension

12/09 18:00 Ruth - Quantum Genomics to announce Phase IIa clinical trial results for high blood pressure on September 29, 2016

30/06 18:00 Ruth - Quantum Genomics Initiates Phase IIa trial for Heart Failure, the second strategic initiative for its BAPAI therapeutic platform

28/06 18:00 Ruth - Quantum Genomics extends its collaboration agreement with its partner in animal health

02/06 18:00 Ruth - Publication of the first issue of Quantum Genomics' shareholder newsletter - June, 2016

31/05 18:00 Ruth - Quantum Genomics symposium at the European Meeting on Hypertension and Cardiovascular Protection

17/05 18:00 Ruth - Quantum Genomics granted two new U.S. patents covering lead product QGC001

26/04 18:00 Ruth - Regulatory authorisations received in France to begin Phase IIa multicentric European trial for heart failure

14/04 18:00 Ruth - 2015 annual report : acceleration of clinical trials, secured financing and internationalisation in progress

24/03 07:30 Ruth - Quantum Genomics Raises EUR 8.6 Million in U.S. and Europe

03/02 18:30 Ruth - Quantum Genomics Expands U.S. Presence to Advance its Development Programs for Cardiovascular Diseases

31/10 16:50 Ruth - Etats-Unis: crime et châtiment chez les Madoff

20/07 19:16 Ruth - Systagenix Wound Management dématérialise le traitement de ses commandes clients grâce à Esker

07/07 09:30 Ruth - Raptor Pharmaceutical obtient des avis d'admission pour deux demandes de brevets clés protégeant sa gamme de produits à base de cystéamine

06/07 12:35 Ruth - Raptor Pharmaceutical Receives Notices of Allowance for Two Key Patent Applications Protecting Its Cysteamine Portfolio